| Q73428700 | AP-4F, antennapedia peptide linked to an amphipathic alpha helical peptide, increases the efficiency of Lipofectamine-mediated gene transfection in endothelial cells |
| Q30398373 | Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system |
| Q45887356 | Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy |
| Q35628925 | Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells |
| Q34634385 | Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo |
| Q35842653 | Gene therapy for proliferative ocular diseases |
| Q43881934 | Generation and characterization of a fusion protein of single-chain fragment variable antibody against hemagglutinin antigen of avian influenza virus and truncated protamine |
| Q45488183 | Highly efficient ex vivo gene delivery into human corneal endothelial cells by recombinant adeno-associated virus |
| Q44712926 | Immunomodulation in penetrating keratoplasty. Current status and perspectives |
| Q35819354 | Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection |
| Q44434547 | Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans |
| Q34982118 | Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea |
| Q31027777 | Prospects for gene therapy in corneal disease |
| Q40016839 | Prospects for genetic modulation of corneal graft survival |
| Q45884490 | RNAi inhibits Coriaria lactone-induced MDR1b overexpression in rat brain microvascular endothelial cells |
| Q34734683 | Recent applications of liposomes in ophthalmic drug delivery. |
| Q38507265 | Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications |
| Q41951959 | Targeting herpetic keratitis by gene therapy. |
| Q35950928 | The design and exogenous delivery of siRNA for post-transcriptional gene silencing. |
| Q44688156 | Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells |
Search more.